GRCE
Grace Therapeutics, Inc.
NASDAQ: GRCE · HEALTHCARE · BIOTECHNOLOGY
$2.10
+0.00% today
Updated 2026-04-29
Market cap
$33.42M
P/E ratio
—
P/S ratio
197.75x
EPS (TTM)
$-0.31
Dividend yield
—
52W range
$2 – $5
Volume
0.8M
Grace Therapeutics, Inc. (GRCE) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $29040.00 | $10475.00 | $707395.00 | $450159.00 | $216288.00 | $27787.00 | — | — | — | $196000.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | -63.9% | +6653.2% | -36.4% | -52.0% | -87.2% | -100.0% | — | — | — | -100.0% | — | — | — |
| Cost of revenue | — | — | $5106.00 | $396943.00 | $262302.00 | $187896.00 | $60082.00 | — | — | — | $76000.00 | $0.00 | $124000.00 | $11000.00 | $7000.00 |
| Gross profit | — | $29040.00 | $5368.00 | $310452.00 | $187857.00 | $28392.00 | $-32294.00 | — | — | — | $120000.00 | $0.00 | $-124000.00 | $-11000.00 | $-7000.00 |
| Gross margin | — | 100.0% | 51.2% | 43.9% | 41.7% | 13.1% | -116.2% | — | — | — | 61.2% | — | — | — | — |
| R&D | $1.12M | $1.57M | $3.12M | $2.94M | $5.45M | $7.05M | $5.58M | $12.13M | $29.37M | $15.97M | $4.17M | $5.56M | $9.97M | $4.63M | $9.51M |
| SG&A | — | $857749.00 | — | $4.19M | $4.45M | $2.86M | $1.51M | $3.12M | $3.80M | $5.80M | $5.51M | $9.66M | $8.08M | $6.45M | $7.16M |
| Operating income | $-1.54M | $-3.19M | $-6.55M | $-6.82M | $-9.71M | $-9.91M | $-7.09M | $-15.25M | $-34.41M | $-24.44M | $-16.42M | $-15.59M | $-52.16M | $-11.31M | $-16.68M |
| Operating margin | — | -10980.3% | -62535.9% | -963.8% | -2156.1% | -4580.5% | -25526.3% | — | — | — | -8377.0% | — | — | — | — |
| EBITDA | $-1.53M | $-2.39M | $-5.86M | $-6.08M | $-8.84M | $-8.04M | $-2.89M | $-14.30M | $-36.76M | $-22.95M | $-9.79M | $-15.34M | $-18.12M | $-14.62M | $-16.67M |
| EBITDA margin | — | -8226.6% | -55922.5% | -859.5% | -1964.0% | -3717.3% | -10414.9% | — | — | — | -4995.9% | — | — | — | — |
| EBIT | $-1.54M | $-3.07M | $-6.53M | $-6.73M | $-10.44M | $-9.91M | $-4.66M | $-16.37M | $-39.09M | $-25.27M | $-10.72M | $-15.59M | $-18.25M | $-14.63M | $-16.68M |
| Interest expense | $431.00 | $1433.00 | $9014.00 | $2622.00 | $876.00 | $3244.00 | $1476.00 | $283411.00 | $278000.00 | $293000.00 | $264000.00 | — | — | — | — |
| Income tax | $1.51M | $3.08M | — | — | — | $0.00 | — | — | — | — | — | $-648000.00 | $-9.54M | $-1.78M | $-3.20M |
| Effective tax rate | -150830100.0% | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 6.2% | 18.4% | 12.1% | 25.1% |
| Net income | $-1.51M | $-3.08M | $-6.54M | $-6.73M | $-10.44M | $-1.32M | $-4.66M | $-16.65M | $-39.37M | $-25.51M | $-19.68M | $-9.82M | $-42.43M | $-12.85M | $-9.57M |
| Net income growth (YoY) | — | -103.9% | -112.6% | -3.0% | -55.0% | +87.3% | -252.4% | -257.2% | -136.4% | +35.2% | +22.9% | +50.1% | -332.1% | +69.7% | +25.6% |
| Profit margin | — | -10592.3% | -62421.6% | -951.7% | -2318.3% | -611.7% | -16777.6% | — | — | — | -10039.8% | — | — | — | — |